Fennec Pharmaceuticals (FENC) intends to engage in a non-brokered offering of its common shares in Canada, at a price of $7.50 per share, with certain of its existing institutional shareholders, for ...
Generic drugmaker Sandoz expects unbranded versions of Novo Nordisk's blockbuster diabetes drug Ozempic to launch in Canada ...
IMCIVREE now publicly covered for weight management due to Bardet-Biedl syndrome (BBS) in Ontario, Alberta, British Columbia, ...
TORONTO--(BUSINESS WIRE)--Today, Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of ...
Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, today announced that Health Canada has approved KYZATREX ® ...
ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...
Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "Canada Pharmaceutical Market Report by ATC / Therapeutic Class, Drug Type, Distribution Channel, Region, and Company Analysis, 2025-2033" report has been ...
Sandoz CEO Richard Saynor predicts biosimilars referencing semaglutide to enter the Canadian market in early in 2026, as the patent protection for Novo Nordisk’s blockbuster drug looms.
ARS Pharmaceuticals Files for Approval of neffy® (Epinephrine Nasal Spray) 2 mg in Canada and the UK
ARS Pharmaceuticals, Inc. has announced the filing for approval of neffy® (epinephrine nasal spray) 2 mg in Canada and the United Kingdom, where it will be marketed as EURneffy®. This follows neffy's ...
The Canadian Press on MSN
Health Canada refuses to explain $20M in pharmaceuticals lost from national stockpile
The Public Health Agency of Canada lost more than $20 million worth of pharmaceutical products from the national stockpile ...
This investment will help build a 103,000-square-foot R&D center and a GMP manufacturing facility in Edmonton, Alberta. The biomanufacturing facility will develop and produce the Entos Fusogenix PLV ...
Bausch Health Companies Inc. (NYSE:BHC) is one of the best cheap stocks under $10 to buy now. Bausch Health Companies Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results